202 reports of this reaction
1.7% of all NORETHINDRONE reports
#14 most reported adverse reaction
MIGRAINE is the #14 most commonly reported adverse reaction for NORETHINDRONE, manufactured by Amneal Pharmaceuticals LLC. There are 202 FDA adverse event reports linking NORETHINDRONE to MIGRAINE. This represents approximately 1.7% of all 11,560 adverse event reports for this drug.
Patients taking NORETHINDRONE who experience migraine should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MIGRAINE is a less commonly reported adverse event for NORETHINDRONE, but still significant enough to appear in the safety profile.
In addition to migraine, the following adverse reactions have been reported for NORETHINDRONE:
The following drugs have also been linked to migraine in FDA adverse event reports:
MIGRAINE has been reported as an adverse event in 202 FDA reports for NORETHINDRONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MIGRAINE accounts for approximately 1.7% of all adverse event reports for NORETHINDRONE, making it a notable side effect.
If you experience migraine while taking NORETHINDRONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.